深谋远虑
发表于 2025-3-21 18:07:36
书目名称Renal Cell Carcinoma影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0826984<br><br> <br><br>书目名称Renal Cell Carcinoma影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0826984<br><br> <br><br>书目名称Renal Cell Carcinoma网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0826984<br><br> <br><br>书目名称Renal Cell Carcinoma网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0826984<br><br> <br><br>书目名称Renal Cell Carcinoma被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0826984<br><br> <br><br>书目名称Renal Cell Carcinoma被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0826984<br><br> <br><br>书目名称Renal Cell Carcinoma年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0826984<br><br> <br><br>书目名称Renal Cell Carcinoma年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0826984<br><br> <br><br>书目名称Renal Cell Carcinoma读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0826984<br><br> <br><br>书目名称Renal Cell Carcinoma读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0826984<br><br> <br><br>
极少
发表于 2025-3-22 00:15:00
Biology of Renal Cell Carcinoma (Vascular Endothelial Growth Factor, Mammalian Target of Rapamycin, vascular endothelial growth factor (VEGF) and mammalian target of rapamycin (mTOR) pathways as well as what perturbations stemming from . loss or mutation can result in advanced RCC. Finally, we will touch on the immunologic monitoring of RCC and the opportunities related to manipulating the immune system for treating patients with advanced RCC.
官僚统治
发表于 2025-3-22 01:44:06
Etiology of Renal Cell Carcinoma: Incidence, Demographics, and Environmental Factors environmental and lifestyle risk factors for renal cell carcinoma (RCC). A wide variability in geographic, gender, and ethnic differences has been observed relative to RCC around the world, with tobacco use, obesity, and hypertension emerging as the primary environmental factors that predispose to RCC.
宏伟
发表于 2025-3-22 06:22:58
http://reply.papertrans.cn/83/8270/826984/826984_4.png
Repatriate
发表于 2025-3-22 11:29:02
Integration of Surgery in Metastatic Renal Cancer the role of debulking cytoreductive nephrectomy (CN) and metastasectomy in mRCC. In addition, the concepts of treatment with a period of targeted therapy prior to CN (upfront therapy) have become a reality. This chapter will give an overview of the historical concepts and recent changes in surgical paradigms.
NATAL
发表于 2025-3-22 14:03:45
Prognostic Factors for Localized Renal Cell Carcinomafor more accurate counseling of patients regarding their likely clinical course, help to classify patients with greatest potential to benefit from adjuvant treatments, and facilitate ongoing cancer surveillance.
tackle
发表于 2025-3-22 18:24:47
http://reply.papertrans.cn/83/8270/826984/826984_7.png
instill
发表于 2025-3-22 22:54:22
http://reply.papertrans.cn/83/8270/826984/826984_8.png
accrete
发表于 2025-3-23 04:28:27
http://reply.papertrans.cn/83/8270/826984/826984_9.png
Infelicity
发表于 2025-3-23 06:16:40
Book 2013 clinicians, surgeons and researchers with an interest in kidney cancer. The volume reviews new data about risk factors for the disease, profiles the new staging system for renal cell carcinoma (RCC), highlights our current understanding of familial syndromes of RCC and their molecular genetics, and